Ashraf K. El‐Damasy

581 total citations
29 papers, 476 citations indexed

About

Ashraf K. El‐Damasy is a scholar working on Organic Chemistry, Molecular Biology and Hematology. According to data from OpenAlex, Ashraf K. El‐Damasy has authored 29 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 15 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Ashraf K. El‐Damasy's work include Synthesis and biological activity (12 papers), Quinazolinone synthesis and applications (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Ashraf K. El‐Damasy is often cited by papers focused on Synthesis and biological activity (12 papers), Quinazolinone synthesis and applications (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Ashraf K. El‐Damasy collaborates with scholars based in Egypt, South Korea and Saudi Arabia. Ashraf K. El‐Damasy's co-authors include Gyochang Keum, Ae Nim Pae, Seon Hee Seo, Ju‐Hyeon Lee, Eun‐Kyoung Bang, Soon Bang Kang, Eunice EunKyeong Kim, Said M. Bayomi, Seon Hee Seo and Mohammad M. Al‐Sanea and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Cancer Letters.

In The Last Decade

Ashraf K. El‐Damasy

28 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashraf K. El‐Damasy Egypt 14 280 244 74 57 41 29 476
Taijin Wang China 10 201 0.7× 264 1.1× 45 0.6× 34 0.6× 124 3.0× 25 447
Youlu Pan China 14 219 0.8× 262 1.1× 76 1.0× 45 0.8× 122 3.0× 38 609
Ana S. Newton United States 13 153 0.5× 147 0.6× 52 0.7× 57 1.0× 85 2.1× 18 387
Eman A. M. Beshr Egypt 18 529 1.9× 212 0.9× 79 1.1× 92 1.6× 64 1.6× 38 700
Heba A. Hassan Egypt 14 387 1.4× 261 1.1× 50 0.7× 36 0.6× 94 2.3× 31 595
Mohammed I. El–Gamal United Arab Emirates 15 227 0.8× 318 1.3× 50 0.7× 42 0.7× 93 2.3× 37 609
Zunhua Yang China 17 348 1.2× 368 1.5× 74 1.0× 121 2.1× 105 2.6× 58 762
Silke M. Bauer Germany 11 135 0.5× 200 0.8× 60 0.8× 17 0.3× 92 2.2× 15 352
Samir Mehndiratta Taiwan 17 384 1.4× 363 1.5× 37 0.5× 60 1.1× 110 2.7× 28 744
Hiroo Koyama Japan 13 235 0.8× 252 1.0× 40 0.5× 51 0.9× 38 0.9× 28 547

Countries citing papers authored by Ashraf K. El‐Damasy

Since Specialization
Citations

This map shows the geographic impact of Ashraf K. El‐Damasy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf K. El‐Damasy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf K. El‐Damasy more than expected).

Fields of papers citing papers by Ashraf K. El‐Damasy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashraf K. El‐Damasy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf K. El‐Damasy. The network helps show where Ashraf K. El‐Damasy may publish in the future.

Co-authorship network of co-authors of Ashraf K. El‐Damasy

This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf K. El‐Damasy. A scholar is included among the top collaborators of Ashraf K. El‐Damasy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf K. El‐Damasy. Ashraf K. El‐Damasy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Damasy, Ashraf K., Ahmed A. Al‐Karmalawy, Radwan Alnajjar, et al.. (2024). Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies. Pharmaceuticals. 17(4). 427–427. 3 indexed citations
2.
Lee, Ji Sun, Hyo‐Jung Park, Sung Pil Kwon, et al.. (2024). A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety. Bioactive Materials. 38. 486–498. 22 indexed citations
3.
El‐Damasy, Ashraf K., Alessio Nocentini, Seon Hee Seo, et al.. (2023). Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2154603–2154603. 14 indexed citations
4.
El‐Damasy, Ashraf K., Jong‐Min Oh, Ahmed A. Al‐Karmalawy, et al.. (2023). Novel coumarin benzamides as potent and reversible monoamine oxidase-B inhibitors: Design, synthesis, and neuroprotective effects. Bioorganic Chemistry. 142. 106939–106939. 8 indexed citations
5.
El‐Damasy, Ashraf K., Jung Woo Park, Yunju Nam, et al.. (2023). Discovery of 3-((3-amino- 1H -indazol-4-yl)ethynyl)- N -(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide (AKE-72), a potent Pan-BCR-ABL inhibitor including the T315I gatekeeper resistant mutant. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2228515–2228515. 1 indexed citations
6.
El‐Damasy, Ashraf K., Jong‐Eun Park, Jinhyuk Lee, et al.. (2023). Identification of New N-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors. Pharmaceuticals. 16(1). 83–83. 14 indexed citations
7.
El‐Damasy, Ashraf K., Mohamed Sabry, Mohammed M. Alanazi, et al.. (2023). Design and Synthesis of New 4-(3,4,5-Trimethoxyphenyl)Thiazole–Pyrimidine Derivatives as Potential Antiproliferative Agents. Medicina. 59(6). 1076–1076. 7 indexed citations
8.
Al‐Warhi, Tarfah, Abeer H. Elmaidomy, Samy Selim, et al.. (2022). The Wound-Healing Potential of Olea europaea L. Cv. Arbequina Leaves Extract: An Integrated In Vitro, In Silico, and In Vivo Investigation. Metabolites. 12(9). 791–791. 20 indexed citations
9.
Wafa, Emad I., Kareem Ebeid, Sean M. Geary, et al.. (2021). Thiophene Derivative‐Loaded Nanoparticles Mediate Anticancer Activity Through the Inhibition of Kinases and Microtubule Assembly. Advanced Therapeutics. 4(7). 12 indexed citations
10.
El‐Damasy, Ashraf K., Ghada S. Hassan, Emad I. Wafa, et al.. (2020). Cyclohepta[b]thiophenes as Potential Antiproliferative Agents: Design, Synthesis, In Vitro, and In Vivo Anticancer Evaluation. ACS Pharmacology & Translational Science. 3(5). 965–977. 13 indexed citations
11.
El‐Damasy, Ashraf K., Seon Hee Seo, Young Ho Seo, et al.. (2020). Structural Basis for Design of New Purine-Based Inhibitors Targeting the Hydrophobic Binding Pocket of Hsp90. International Journal of Molecular Sciences. 21(24). 9377–9377. 9 indexed citations
12.
El‐Damasy, Ashraf K., Md. Mamunul Haque, Jung Woo Park, et al.. (2020). 2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAFV600E/C-RAF kinase inhibitory effects: Design, synthesis, in vitro cell-based and oncogenic kinase assessments. European Journal of Medicinal Chemistry. 208. 112756–112756. 21 indexed citations
13.
Alkhaldi, Abdulsalam A. M., Mohammad M. Al‐Sanea, Alessio Nocentini, et al.. (2020). 3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies. European Journal of Medicinal Chemistry. 207. 112745–112745. 62 indexed citations
14.
El‐Damasy, Ashraf K., et al.. (2020). Design, synthesis, and biological evaluations of novel 3-amino-4-ethynyl indazole derivatives as Bcr-Abl kinase inhibitors with potent cellular antileukemic activity. European Journal of Medicinal Chemistry. 207. 112710–112710. 10 indexed citations
15.
El‐Damasy, Ashraf K., et al.. (2020). Synthesis, in vivo anti-inflammatory, COX-1/COX-2 and 5-LOX inhibitory activities of new 2,3,4-trisubstituted thiophene derivatives. Bioorganic Chemistry. 102. 103890–103890. 25 indexed citations
16.
Fang, Zhenghuan, Kyung Hee Jung, Ju‐Hyeon Lee, et al.. (2018). A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancer. Cancer Letters. 426. 25–36. 7 indexed citations
17.
El‐Damasy, Ashraf K., et al.. (2016). Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-RafV600E and C-Raf kinase inhibitory activities. European Journal of Medicinal Chemistry. 115. 201–216. 61 indexed citations
18.
19.
El‐Damasy, Ashraf K., et al.. (2015). ABL kinase inhibitory and antiproliferative activity of novel picolinamide based benzothiazoles. Bioorganic & Medicinal Chemistry Letters. 25(10). 2162–2168. 20 indexed citations
20.
El‐Damasy, Ashraf K., Seon Hee Seo, Soon Bang Kang, et al.. (2015). Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives. European Journal of Medicinal Chemistry. 101. 754–768. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taijin Wang Breakdown of academic impact, for papers by Youlu Pan Breakdown of academic impact, for papers by Ana S. Newton Breakdown of academic impact, for papers by Eman A. M. Beshr Breakdown of academic impact, for papers by Heba A. Hassan Breakdown of academic impact, for papers by Mohammed I. El–Gamal Breakdown of academic impact, for papers by Zunhua Yang Breakdown of academic impact, for papers by Silke M. Bauer Breakdown of academic impact, for papers by Samir Mehndiratta Breakdown of academic impact, for papers by Hiroo Koyama
Rankless by CCL
2026